Skip to main content

MW 357.4 Da, Purity >99%. Selective PPARγ agonist (EC50 = 43 nM). Thiazolidinedione. Mediates adipocyte differentiation, increases lipogenesis and enhances fatty acid and glucose uptake. Promotes differentiation of urothelial organoids; potent and selective PPARγ agonist.

Be the first to review this product! Submit a review

Images

Chemical Structure - Rosiglitazone, PPARgamma agonist (AB120762), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - Rosiglitazone, PPARgamma agonist (AB120762), expandable thumbnail

Publications

Key facts

CAS number
122320-73-4
Purity
> 99%
Form
Solid
Molecular weight
357.4 Da
Molecular formula
C18H19N3O3S
PubChem identifier
77999
Nature
Synthetic

Recommended products

MW 357.4 Da, Purity >99%. Selective PPARγ agonist (EC50 = 43 nM). Thiazolidinedione. Mediates adipocyte differentiation, increases lipogenesis and enhances fatty acid and glucose uptake. Promotes differentiation of urothelial organoids; potent and selective PPARγ agonist.

Key facts

Purity
> 99%
PubChem identifier
77999
Solubility

Soluble in DMSO to 100 mM.

Soluble in ethanol to 100 mM (with warming).

Biochemical name
Rosiglitazone
Biological description

Selective PPARγ agonist (EC50 = 43 nM). Thiazolidinedione. Mediates adipocyte differentiation, increases lipogenesis and enhances fatty acid and glucose uptake. Promotes differentiation of urothelial organoids; potent and selective PPARγ agonist.

Canonical SMILES
CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
InChI
InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)
InChIKey
YASAKCUCGLMORW-UHFFFAOYSA-N
IUPAC name
5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions, The product can be stored for up to 12 months

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - Rosiglitazone, PPARgamma agonist (ab120762), expandable thumbnail

    Chemical Structure - Rosiglitazone, PPARgamma agonist (ab120762)

    2D chemical structure image of ab120762, Rosiglitazone, PPARgamma agonist

  • Immunocytochemistry/ Immunofluorescence - Rosiglitazone, PPARgamma agonist (ab120762), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Rosiglitazone, PPARgamma agonist (ab120762)

    Anti-Glucocorticoid Receptor alpha antibody ab3580 staining glucocorticoid receptor in serum starved HeLa cells treated with rosiglitazone (120762), by ICC/IF. Changes in localization of glucocorticoid receptor (translocation from cytoplasm to nucleous) correlates with increased concentration of rosiglitazone, as described in literature.
    The cells were incubated at 37°C for 1h in media containing different concentrations of ab120762 (rosiglitazone) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with Anti-Glucocorticoid Receptor alpha antibody ab3580 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com